|BP||399.7°C at 760 mmHg|
|Appearance||White Crystalline Powder|
Aniracetam is a popular choice among nootropic users for its ability to enhance cognition while reducing anxiety and boosting mood. It’s also moderately priced and has little side effects when taken at recommended dosages. Aniracetam is chemically classed as a racetam, and like most racetams, it works to a large extent by modulating neurotransmitters.
Aniracetam, also known as N-anisoyl-2-pyrrolidinone, is an ampakine nootropic of the racetam chemical class purported to be considerably more potent than piracetam. It is lipid-soluble and has possible cognition-enhancing effects. It has been tested in animals extensively, Alzheimer’s patients, and temporarily impaired healthy subjects.
As stated above, Aniracetam can have many off-label uses. It is considered a fairly safe and low toxicity substance to improve cognition and memory or reduce anxiety symptoms. Like other racetams, it can have an added benefit of reducing free radicals and oxidative stress in the brain which can lead to degenerative diseases and neurological complications. It should not be used as a main line of defence or treatment for degenerative diseases like Alzheimer’s and Dementia but may have merit in reducing some of the symptoms associated. Below, are some of the common observed benefits of Aniracetam. Results may vary.
Increased Learning Ability
Improved Cognitive Processing
While individual requirements vary, a dosage of 750-1500 mg is typically accepted as both safe and effective, though doses of up to 3000 mg daily have been documented as well-tolerated. It is wise to start with the minimum effective dose and gradually increase as necessary. One human study involving individuals with senile cognitive disorders reported benefits over placebo at 1500 mg/day.
Because of its relatively brief half-life of one to three hours, dosage may have to be repeated at intervals to maintain effects. Like most nootropics in the racetam family, the effects of aniracetam may diminish if too much is present in the system, so dosage should be monitored closely.
When taken at recommended dosages, aniracetam produces very few documented side effects, and those that are reported are both minor and temporary. The most frequently reported side effects of aniracetam are headaches and mild nausea, both of which can often be successfully addressed by the addition of a choline source.
High doses of aniracetam can result in a feeling of excessive nervousness, digestive discomfort, or both. If either of these effects occurs, try reducing dosage. Some users report a loss of inhibition when taking aniracetam; while not necessarily an unwelcome side effect, a sudden feeling of loss of inhibition could be surprising and perhaps unsettling (especially in retrospect).